Literature DB >> 28932524

Inflammation, phagocytosis and cancer: another step in the CD47 act.

Maria A Smolle1, Martin Pichler2.   

Abstract

Entities:  

Year:  2017        PMID: 28932524      PMCID: PMC5594199          DOI: 10.21037/jtd.2017.07.38

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

2.  What are super-enhancers?

Authors:  Sebastian Pott; Jason D Lieb
Journal:  Nat Genet       Date:  2015-01       Impact factor: 38.330

Review 3.  The genomic landscape of breast cancer and its interaction with host immunity.

Authors:  Stephen Luen; Balaji Virassamy; Peter Savas; Roberto Salgado; Sherene Loi
Journal:  Breast       Date:  2016-10       Impact factor: 4.380

4.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen B Willingham; Jens-Peter Volkmer; Andrew J Gentles; Debashis Sahoo; Piero Dalerba; Siddhartha S Mitra; Jian Wang; Humberto Contreras-Trujillo; Robin Martin; Justin D Cohen; Patricia Lovelace; Ferenc A Scheeren; Mark P Chao; Kipp Weiskopf; Chad Tang; Anne Kathrin Volkmer; Tejaswitha J Naik; Theresa A Storm; Adriane R Mosley; Badreddin Edris; Seraina M Schmid; Chris K Sun; Mei-Sze Chua; Oihana Murillo; Pradeep Rajendran; Adriel C Cha; Robert K Chin; Dongkyoon Kim; Maddalena Adorno; Tal Raveh; Diane Tseng; Siddhartha Jaiswal; Per Øyvind Enger; Gary K Steinberg; Gordon Li; Samuel K So; Ravindra Majeti; Griffith R Harsh; Matt van de Rijn; Nelson N H Teng; John B Sunwoo; Ash A Alizadeh; Michael F Clarke; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

7.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

8.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

9.  CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.

Authors:  Kazumichi Yoshida; Hironori Tsujimoto; Kouji Matsumura; Manabu Kinoshita; Risa Takahata; Yusuke Matsumoto; Shuichi Hiraki; Satoshi Ono; Shuhji Seki; Junji Yamamoto; Kazuo Hase
Journal:  Cancer Med       Date:  2015-06-16       Impact factor: 4.452

10.  A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer.

Authors:  Paola A Betancur; Brian J Abraham; Ying Y Yiu; Stephen B Willingham; Farnaz Khameneh; Mark Zarnegar; Angera H Kuo; Kelly McKenna; Yoko Kojima; Nicholas J Leeper; Po Ho; Phung Gip; Tomek Swigut; Richard I Sherwood; Michael F Clarke; George Somlo; Richard A Young; Irving L Weissman
Journal:  Nat Commun       Date:  2017-04-05       Impact factor: 14.919

View more
  4 in total

Review 1.  Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Authors:  Sachin Kumar Deshmukh; Sanjeev Kumar Srivastava; Teja Poosarla; Donna Lynn Dyess; Nicolette Paolaungthong Holliday; Ajay Pratap Singh; Seema Singh
Journal:  Ann Transl Med       Date:  2019-10

Review 2.  Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: Challenges and potentials for human applications.

Authors:  Irene Paraboschi; Stephen Turnock; Gabriela Kramer-Marek; Layla Musleh; Marta Barisa; John Anderson; Stefano Giuliani
Journal:  Crit Rev Oncol Hematol       Date:  2021-04-06       Impact factor: 6.312

3.  CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.

Authors:  Shin Pai; Oluwaseun Adebayo Bamodu; Yen-Kuang Lin; Chun-Shu Lin; Pei-Yi Chu; Ming-Hsien Chien; Liang-Shun Wang; Michael Hsiao; Chi-Tai Yeh; Jo-Ting Tsai
Journal:  Cells       Date:  2019-12-17       Impact factor: 6.600

Review 4.  The Phagocytic Code Regulating Phagocytosis of Mammalian Cells.

Authors:  Tom O J Cockram; Jacob M Dundee; Alma S Popescu; Guy C Brown
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.